Garam Kim

METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation

Poshan Yugal Bhattarai, Garam Kim, Muna Poudel et al. · Cancer Letters · 2021 · 71 citations

Medicine, Molecular Biology, Oncology +13

Discovery of New Imidazo[2,1-<i>b</i>]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising <i>In Vitro</i> and <i>In Vivo</i> Anti-melanoma Activity

Mohammed S. Abdel‐Maksoud, Mohammed I. El–Gamal, Bong S. Lee et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer

Prem Khanal, Garam Kim, Sung‐Chul Lim et al. · The FASEB Journal · 2013 · 37 citations

Medicine, Cancer Biology, Oncology +17

New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: Synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies

Eun Jeong Koh, Mohammed I. El‐Gamal, Chang-Hyun Oh et al. · European Journal of Medicinal Chemistry · 2013 · 28 citations

Pharmacy, Medicinal Chemistry, Oncology +15

Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy

Garam Kim, Subin Kim, Yeo Ok Kim et al. · Journal of Medicinal Chemistry · 2024 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17